Perilstein Michael D MD is categorized under Rheumatologists in Pottstown, PA and active since 1980.
Perilstein Michael D MD was established in 1980, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Perilstein at the company’s single location by writing to 13 Armand Hammer Boulevard # 210, Pottstown, Pennsylvania PA 19464 or by phoning (610) 327-2405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Perilstein Michael D MD |
| Contact Person: | Michael Perilstein |
| Address: | 13 Armand Hammer Boulevard # 210, Pottstown, Pennsylvania 19464 |
| Phone Number: | (610) 327-2405 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1980 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rheumatologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Perilstein Michael D MD was started in 1980 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Perilstein for inquiries that concern Perilstein Michael D MD by calling the company number (610) 327-2405, as your correspondence is most welcome. Additionally, the physical location of the single location of Perilstein Michael D MD can be found at the coordinates 40.24385,-75.61359 as well as the street address 13 Armand Hammer Boulevard # 210 in Pottstown, Pennsylvania 19464.
For its online presence, you may visit Perilstein Michael D MD’s website at and engage with its social media outlets through on Twitter and on Facebook.